⌘K
t
| Date | 17 Aug 2023 |
| Time | 13:39:35 |
| Category | Miscellaneous |
| ID | 6812J |
17 August 2023
TruSpine Technologies plc
("TruSpine" or the "Company")
Result of Aquis Disciplinary Investigation
TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering "screwless," spinal (vertebral) stabilisation systems notes the publication of the public censure and fine of £215,000 on the Company by Aquis Stock Exchange. The Company intends to appeal certain aspects of the Disciplinary Notice. Full details of the public censure and fine can be found in the Disciplinary Notice published on 16 August 2023 (see link below).
https://www.aquis.eu/stock-exchange/rules-and-regulations/market-notices
This announcement contains inside information for the purposes of the UK Market Abuse Regulation, and the Directors of the Company are responsible for the release of this announcement.
Enquiries:
|
TruSpine Technologies Plc |
Tel: +44 (0)20 7118 0852 |
|
Laurence Strauss, Chief Executive Officer |
|
|
|
|
|
Cairn Financial Advisers LLP (AQSE Corporate Adviser) |
Tel: +44 (0)20 7213 0880 |
|
Liam Murray / Ludovico Lazzaretti |
|
|
Peterhouse Capital Limited (Broker & Financial Adviser) |
|
|
Lucy Williams / Duncan Vasey
|
|
|
Novus Communications (PR and IR) |
Tel: +44 (0)20 7448 9839 |
|
Alan Green / Jacqueline Briscoe |
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.